EKF, Angle Collaborate for Liquid Biopsy Development | GenomeWeb

NEW YORK (GenomeWeb) – EKF Molecular Diagnostics will collaborate with medical technology firm Angle for liquid biopsy development, the companies announced today.

The UK-headquartered companies aim to initially investigate applications for colorectal cancer diagnostics combining EKF's PointMan DNA enrichment technology with Angle’s Parsortix circulating tumor cell (CTC) harvesting platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.